Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

685.47
Delayed Data
As of Sep 26
 -11.86 / -1.70%
Today’s Change
538.01
Today|||52-Week Range
754.67
+8.54%
Year-to-Date

Today’s Trading

Previous close697.33
Today’s open695.93
Day’s range682.71 - 696.09
Volume39,016
Average volume (3 months)703,635
Market cap$76.0B
Data as of 4:01pm ET, 09/26/2022

Growth & Valuation

Earnings growth (last year)+133.99%
Earnings growth (this year)-43.90%
Earnings growth (next 5 years)+1.50%
Revenue growth (last year)+89.14%
P/E ratio13.7
Price/Sales4.41
Price/Book4.04

Competitors

----
VRTXVertex Pharmaceutica...-6.67-2.35%
ZTSZoetis Inc-1.36-0.91%
----
Data as of 4:01pm ET, 09/26/2022

Financials

Next reporting dateNovember 8, 2022
EPS forecast (this quarter)$9.85
Annual revenue (last year)$16.1B
Annual profit (last year)$8.1B
Net profit margin50.25%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Tarrytown, New York

Forecasts